The Institute of Cancer Research at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
The Institute of Cancer Research brings 4 presentations to ENA 2026 in Barcelona. Its program centres on the tumour microenvironment and its part in treatment resistance, including chemoresistance in triple negative breast cancer. It also covers fibroblast activation protein (FAP) as a therapy target and protein degradation models for testing spliceosome-associated RNA helicases as targets.
| Organization | ENA 2026 Attendance |
|---|---|
The Institute of Cancer Research London, UK | |
London cancer research institute and college of the University of London, with a drug discovery centre; partnered with The Royal Marsden. | Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Session Thu Nov 19 5–6:30pm Talk Thu Nov 19 6–6:20pm |
Instantly find 20 buyers from The Institute of Cancer Research
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction